Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 5 de 5
Filtrer
1.
Cancer Discov ; 14(8): 1457-1475, 2024 Aug 02.
Article de Anglais | MEDLINE | ID: mdl-38587317

RÉSUMÉ

Microsatellite-unstable (MSI) cancers require WRN helicase to resolve replication stress due to expanded DNA (TA)n dinucleotide repeats. WRN is a promising synthetic lethal target for MSI tumors, and WRN inhibitors are in development. In this study, we used CRISPR-Cas9 base editing to map WRN residues critical for MSI cells, validating the helicase domain as the primary drug target. Fragment-based screening led to the development of potent and highly selective WRN helicase covalent inhibitors. These compounds selectively suppressed MSI model growth in vitro and in vivo by mimicking WRN loss, inducing DNA double-strand breaks at expanded TA repeats and DNA damage. Assessment of biomarkers in preclinical models linked TA-repeat expansions and mismatch repair alterations to compound activity. Efficacy was confirmed in immunotherapy-resistant organoids and patient-derived xenograft models. The discovery of potent, selective covalent WRN inhibitors provides proof of concept for synthetic lethal targeting of WRN in MSI cancer and tools to dissect WRN biology. Significance: We report the discovery and characterization of potent, selective WRN helicase inhibitors for MSI cancer treatment, with biomarker analysis and evaluation of efficacy in vivo and in immunotherapy-refractory preclinical models. These findings pave the way to translate WRN inhibition into MSI cancer therapies and provide tools to investigate WRN biology. See related commentary by Wainberg, p. 1369.


Sujet(s)
Werner syndrome helicase , Humains , Werner syndrome helicase/génétique , Souris , Animaux , Instabilité des microsatellites , Tumeurs/traitement médicamenteux , Tumeurs/génétique , Tumeurs/anatomopathologie , Lignée cellulaire tumorale , Tests d'activité antitumorale sur modèle de xénogreffe , Antienzymes/pharmacologie , Antienzymes/usage thérapeutique
2.
Holist Nurs Pract ; 35(2): 57-59, 2021.
Article de Anglais | MEDLINE | ID: mdl-33156127

RÉSUMÉ

Nurses directly influence the experience that patients and their families have in their interactions with the health care system. This article addresses how nurses holistically influence the patient experience through the lens of health literacy, as nurses guide their patients and families through a confusing and complex system of care, replete with jargon and labyrinthine paths.


Sujet(s)
Compétence informationnelle en santé/normes , Satisfaction des patients , Compétence informationnelle en santé/méthodes , Compétence informationnelle en santé/statistiques et données numériques , Humains , Relations entre professionnels de santé et patients
4.
Holist Nurs Pract ; 32(3): 123-124, 2018.
Article de Anglais | MEDLINE | ID: mdl-29642125

RÉSUMÉ

Despite public knowledge of advanced directives and end-of-life wishes, desire for control over destiny often conflicts with the reality of end-of-life presentation. Recognized as best practice by both the Emergency Nurses Association and the American College of Emergency Physicians, family presence during resuscitation can actually prevent unintended harm to patients and their families.


Sujet(s)
Réanimation cardiopulmonaire/méthodes , Politique de planification familiale , Attitude du personnel soignant , Service hospitalier d'urgences/organisation et administration , Service hospitalier d'urgences/tendances , Humains
5.
Bioorg Med Chem Lett ; 22(9): 3366-9, 2012 May 01.
Article de Anglais | MEDLINE | ID: mdl-22460029

RÉSUMÉ

A novel series of N-substituted tropane derivatives was characterized as potent muscarinic acetylcholine receptor antagonists (mAChRs). Kinetic washout studies showed that the N-endosubstituted analog 24 displayed much slower reversibility at mAChRs than the methyl-substituted parent molecule darotropium. In addition, it was shown that this characteristic appeared to translate into enhanced which duration of action in a mouse model of bronchonstriction.


Sujet(s)
Antagonistes muscariniques/synthèse chimique , Tropanes/synthèse chimique , Animaux , Maladies des bronches/traitement médicamenteux , Conception de médicament , Souris , Antagonistes muscariniques/pharmacologie , Récepteur muscarinique/effets des médicaments et des substances chimiques , Relation structure-activité , Tropanes/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE